<SEC-DOCUMENT>0001493152-18-012669-index.html : 20180829
<SEC-HEADER>0001493152-18-012669.hdr.sgml : 20180829
<ACCEPTANCE-DATETIME>20180828184601
ACCESSION NUMBER:		0001493152-18-012669
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20180827
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180829
DATE AS OF CHANGE:		20180828

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OncoCyte Corp
		CENTRAL INDEX KEY:			0001642380
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				271041563
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37648
		FILM NUMBER:		181042716

	BUSINESS ADDRESS:	
		STREET 1:		1010 ATLANTIC AVENUE
		STREET 2:		SUITE 102
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94501
		BUSINESS PHONE:		510-775-0515

	MAIL ADDRESS:	
		STREET 1:		1010 ATLANTIC AVENUE
		STREET 2:		SUITE 102
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94501
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
Document 1 - file: form8-k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<TEXT>
Document 2 - file: ex3-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99-1.htm
<TEXT>
Document 3 - file: ex99-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>ex99-2.htm
<TEXT>
Document 4 - file: ex99-2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>5
<FILENAME>ex99-3.htm
<TEXT>
Document 5 - file: ex99-3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.4
<SEQUENCE>6
<FILENAME>ex99-4.htm
<TEXT>
Document 6 - file: ex99-4.htm

</DOCUMENT>
</SEC-DOCUMENT>